Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 01-2017 | 10-2016 | 07-2016 | 04-2016 | |
| Sales | 11 | 13,535 | 1,121 | 0 | 2,605 |
| Gross Profit | 11 | 13,535 | 1,121 | N/A | 2,605 |
| Operating Expenses | 2,832 | 2,897 | 1,700 | 0 | 2,193 |
| Operating Income | -2,821 | 10,638 | -579 | N/A | 412 |
| Other Income | 24 | 12 | -22 | 0 | 4 |
| Pre-tax Income | -2,797 | 10,650 | -601 | 0 | 416 |
| Net Income Continuous | -2,797 | 10,650 | -601 | N/A | 416 |
| Net Income | $-2,797 | $10,650 | $-601 | $N/A | $416 |
| EPS Basic Total Ops | -1.39 | 5.31 | -0.30 | N/A | 0.22 |
| EPS Basic Continuous Ops | -1.39 | 5.31 | -0.30 | N/A | 0.22 |
| EPS Diluted Total Ops | -1.39 | 4.91 | -0.30 | N/A | 0.15 |
| EPS Diluted Continuous Ops | -1.39 | 4.91 | -0.30 | N/A | 0.15 |
| EBITDA(a) | $-2,819 | $10,640 | $-578 | $N/A | $412 |